DBV Technologies
Yahoo Finance • 14 days ago
DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
Châtillon, France, November 4, 2025 DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a cli... Full story
Yahoo Finance • 14 days ago
DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation
Châtillon, France, le 4 novembre (22 :30 CET) 2025 DBV Technologies participera à la 2e conférence annuelle Guggenheim Healthcare Innovation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT— CUSIP : 233... Full story
Yahoo Finance • 19 days ago
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
Châtillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stag... Full story
Yahoo Finance • 19 days ago
DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration
Châtillon, France, 30 octobre 2025 DBV Technologies annonce la nomination de Philina Lee, Ph.D. au sein de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la « Société » ou « DBV... Full story
Yahoo Finance • 20 days ago
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
Châtillon, France, October 29, 2025 DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT... Full story
Yahoo Finance • 20 days ago
DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
Châtillon, France, 29 octobre 2025 DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (la « Société » ou « DBV... Full story
Yahoo Finance • 21 days ago
DBV Technologies Reports Third Quarter 2025 Financial Results
Châtillon, France, October 28, 2025 DBV Technologies Reports Third Quarter 2025 Financial Results DBV closes Q3 2025 with a cash and cash equivalents balance of $69.8 million, taking cash runway into the third quarter of 2026 DBV Techno... Full story
Yahoo Finance • 21 days ago
DBV Technologies publie ses résultats financiers du troisième trimestre 2025
Châtillon, France, 28 octobre 2025 DBV Technologies publie ses résultats financiers du troisième trimestre 2025 DBV clôture le troisième trimestre 2025 avec un solde de trésorerie & équivalents de trésorerie de 69,8 millions de dollars p... Full story
Yahoo Finance • 2 months ago
DBV Technologies Announces Resignation of Board Member
Châtillon, France, September 18, 2025 DBV Technologies Announces Resignation of Board Member DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical compan... Full story
Yahoo Finance • 2 months ago
DBV Technologies annonce la démission d’un membre de son Conseil d’administration
Châtillon, France, le 18 septembre 2025 DBV Technologies annonce la démission d’un membre de son Conseil d’administration DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (la “Société” ou “DBV”), une société b... Full story
Yahoo Finance • 2 months ago
DBV Technologies launches $150M ATM offering
* DBV Technologies (NASDAQ:DBVT [https://seekingalpha.com/symbol/DBVT]) filed a prospectus supplement with the SEC for an at-the-market offering up to $150M of American Depositary Shares. * Each ADS represents five ordinary shares of t... Full story
Yahoo Finance • 2 months ago
DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq
Châtillon, France, September 5, 2025 DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT) (the “Company”), a clinical-stage biopharmaceu... Full story
Yahoo Finance • 2 months ago
DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq
Châtillon, France, le 5 septembre (22:30 CEST) 2025 DBV Technologies met en place un Programme At-The-Market (ATM) sur le Nasdaq DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Capital Market : DBVT) (la « Société »), une... Full story
Yahoo Finance • 2 months ago
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Châtillon, France, September 3, 2025 DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a... Full story
Yahoo Finance • 2 months ago
DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment
Châtillon, France, le 3 septembre (22:30 CEST) 2025 DBV Technologies participera à la 27e conférence annuelle H.C. Wainwright Global Investment DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP :... Full story
Yahoo Finance • 4 months ago
DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report
Châtillon, France, July 29, 2025 DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical... Full story
Yahoo Finance • 4 months ago
DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation
Châtillon, France, le 29 juillet 2025 DBV Technologies publie son Rapport Financier Semestriel 2025 ― Modalités de mise à disposition ou de consultation DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société... Full story
Yahoo Finance • 4 months ago
DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results
Châtillon, France, July 29, 2025 DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharm... Full story
Yahoo Finance • 4 months ago
DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025
Châtillon, France, le 29 juillet 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP : 23306J309), société... Full story
Yahoo Finance • 4 months ago
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
AMF Regulated Information Châtillon, France, July 28, 2025 Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage bio... Full story
